Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Consumer Quality Index Chronic Skin Diseases (CQI-CSD): a new instrument to measure quality of care from patients' perspective.

van Cranenburgh OD, Krol MW, Hendriks M, de Rie MA, Smets EM, de Korte J, Sprangers MA.

Br J Dermatol. 2015 Jun 22. doi: 10.1111/bjd.13957. [Epub ahead of print]

PMID:
26099516
2.

Autologous cell suspension transplantation using a cell extraction device in segmental vitiligo and piebaldism patients: A randomized controlled pilot study.

Komen L, Vrijman C, Tjin EP, Krebbers G, de Rie MA, Luiten RM, van der Veen JP, Wolkerstorfer A.

J Am Acad Dermatol. 2015 Jul;73(1):170-2. doi: 10.1016/j.jaad.2015.03.036. No abstract available.

PMID:
26089056
3.

Timed exposure 10,600 nm CO2 laser drilling in various benign dermal tumours.

Meesters AA, De Rie MA, Wolkerstorfer A.

Eur J Dermatol. 2015 Jun 12. [Epub ahead of print] No abstract available.

PMID:
26066586
4.

Fractional CO2 laser assisted delivery of topical anesthetics: A randomized controlled pilot study.

Meesters AA, Bakker MM, de Rie MA, Wolkerstorfer A.

Lasers Surg Med. 2015 May 29. doi: 10.1002/lsm.22376. [Epub ahead of print]

PMID:
26032635
5.

The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: results of a multi-centre randomised controlled trial.

Prinsen CA, Spuls PI, Lindeboom R, Sprangers MA, de Rie MA, de Korte J.

Br J Dermatol. 2015 May 15. doi: 10.1111/bjd.13906. [Epub ahead of print]

PMID:
25975387
6.

The validity, reliability and acceptability of the SAVASI; a new self-assessment score in vitiligo.

Komen L, van der Kraaij GE, van der Veen JP, de Rie MA, Wolkerstorfer A.

J Eur Acad Dermatol Venereol. 2015 Apr 13. doi: 10.1111/jdv.13161. [Epub ahead of print]

PMID:
25868111
7.

Fractionated carbon dioxide laser therapy as treatment of mild rhinophyma: report of three cases.

Meesters AA, van der Linden MM, De Rie MA, Wolkerstorfer A.

Dermatol Ther. 2015 May;28(3):147-50. doi: 10.1111/dth.12205. Epub 2015 Mar 5.

PMID:
25753618
8.

Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo.

Komen L, da Graça V, Wolkerstorfer A, de Rie MA, Terwee CB, van der Veen JP.

Br J Dermatol. 2015 Feb;172(2):437-43. doi: 10.1111/bjd.13432. Epub 2015 Jan 8.

PMID:
25278165
9.

The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells.

Teunissen MB, Yeremenko NG, Baeten DL, Chielie S, Spuls PI, de Rie MA, Lantz O, Res PC.

J Invest Dermatol. 2014 Dec;134(12):2898-907. doi: 10.1038/jid.2014.261. Epub 2014 Jun 18.

PMID:
24945094
10.

A Web-based, educational, quality-of-life intervention for patients with a chronic skin disease: feasibility and acceptance in routine dermatological practice.

van Cranenburgh OD, Smets EM, de Rie MA, Sprangers MA, de Korte J.

Acta Derm Venereol. 2015 Jan;95(1):51-6. doi: 10.2340/00015555-1872.

11.

Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis.

Menting SP, Sitaram AS, Bonnerjee-van der Stok HM, de Rie MA, Hooft L, Spuls PI.

Br J Dermatol. 2014 Oct;171(4):875-83. doi: 10.1111/bjd.13001. Epub 2014 Aug 21.

PMID:
24673245
12.

Q-switched laser depigmentation in vitiligo, most effective in active disease.

Komen L, Zwertbroek L, Burger SJ, van der Veen JP, de Rie MA, Wolkerstorfer A.

Br J Dermatol. 2013 Dec;169(6):1246-51. doi: 10.1111/bjd.12571.

PMID:
23909405
13.

Port-wine stain progression: is prevention by pulsed dye laser therapy possible?

van Drooge AM, de Rie M, van der Veen W, Wolkerstorfer A.

Eur J Dermatol. 2013 Apr 1;23(2):282-3. doi: 10.1684/ejd.2013.1998. No abstract available.

PMID:
23608049
14.

Satisfaction with treatment among patients with psoriasis: a web-based survey study.

van Cranenburgh OD, de Korte J, Sprangers MA, de Rie MA, Smets EM.

Br J Dermatol. 2013 Aug;169(2):398-405. doi: 10.1111/bjd.12372.

PMID:
23565643
15.

A prospective, randomized, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on lesional and nonlesional skin.

de Groot M, Picavet DI, van Kuijk AW, Tak PP, Bos JD, de Rie MA, Teunissen MB.

Dermatology. 2012;225(4):298-303. doi: 10.1159/000343290. Epub 2012 Dec 21.

PMID:
23257348
16.
17.

Long-pulsed 1064 nm Nd:YAG laser improves hypertrophic port-wine stains.

van Drooge AM, Bosveld B, van der Veen JP, de Rie MA, Wolkerstorfer A.

J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1381-6. doi: 10.1111/jdv.12021. Epub 2012 Oct 24.

PMID:
23094931
18.

Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.

Lebre MC, Jonckheere CL, Kraan MC, van Kuijk AW, Bos JD, de Rie M, Gerlag DM, Tak PP.

Arthritis Res Ther. 2012 Sep 24;14(5):R200. doi: 10.1186/ar4038.

19.

Rise in dermal CD11c+ dendritic cells associates with early-stage development of psoriatic lesions.

Teunissen MB, Zheng L, de Groot M, de Rie MA, Fine JS, Chen SC.

Arch Dermatol Res. 2012 Aug;304(6):443-9. doi: 10.1007/s00403-012-1231-7. Epub 2012 Mar 22.

20.

Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor.

Skvara H, Kalthoff F, Meingassner JG, Wolff-Winiski B, Aschauer H, Kelleher JF, Wu X, Pan S, Mickel L, Schuster C, Stary G, Jalili A, David OJ, Emotte C, Antunes AM, Rose K, Decker J, Carlson I, Gardner H, Stuetz A, Bertolino AP, Stingl G, De Rie MA.

J Invest Dermatol. 2011 Aug;131(8):1735-44. doi: 10.1038/jid.2011.48. Epub 2011 Mar 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk